SCHEMBL1614304

SCHEMBL1614304

CC(C)c1ccc(CN2C(=O)S/C(=C\c3cc(O)c(O)c(C(F)(F)F)c3)C2=O)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC2A1 P11166 2/20 0.52
▸ MEN1 O00255 3/20 0.47
▸ KMT2A Q03164 3/20 0.47
▸ ALDH1A1 P00352 2/20 0.47
▸ MAPT P10636 2/20 0.47
▸ MCL1 Q07820 2/20 0.47
▸ L3MBTL1 Q9Y468 2/20 0.47
▸ KDM4E B2RXH2 1/20 0.47
▸ DNMT1 P26358 1/20 0.47
▸ MAPK1 P28482 1/20 0.47
▸ DUSP3 P51452 1/20 0.47
▸ TDP1 Q9NUW8 1/20 0.47
▸ PIM1 P11309 1/20 0.47
▸ LMNA P02545 1/20 0.47
▸ PTPN1 P18031 4/20 0.46
▸ ACP1 P24666 4/20 0.46
▸ ALOX5 P09917 1/20 0.46
▸ NLRP3 Q96P20 1/20 0.44
▸ ENPP2 Q13822 3/20 0.44
▸ COMT P21964 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1614307 0.89 SLC2A1 (0.66) SLC2A1MEN1KMT2AALDH1A1MAPT
SCHEMBL1614940 0.87 SLC2A1 (0.52) SLC2A1MEN1KMT2AALDH1A1MAPT
SCHEMBL1614533 0.87 NLRP3 (0.55) SLC2A1MEN1KMT2APIM1PTPN1
SCHEMBL12712449 0.86 MEN1 (0.50) MEN1KMT2AALDH1A1MAPTMCL1
SCHEMBL1615131 0.83 SLC2A1 (0.61) SLC2A1COMTPPARG
SCHEMBL1614943 0.80 PIM1 (0.53) SLC2A1MEN1KMT2AALDH1A1TDP1
SCHEMBL12712430 0.79 PTPN1 (0.56) SLC2A1MEN1KMT2AALDH1A1MAPT
SCHEMBL1614974 0.79 SLC2A1 (0.77) SLC2A1MEN1KMT2AALDH1A1MAPT
SCHEMBL1612918 0.78 PPARG (0.50) MEN1KMT2AALDH1A1MAPTMCL1
SCHEMBL13754218 0.78 SLC2A1 (0.64) SLC2A1MEN1KMT2AALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2488027-A1 THIAZOLIDINEDIONE ENERGY RESTRICTION-MIMETIC AGENTS The Ohio State University Research Foundation (US) 2012-08-22 — — EP claimed
WO-2011044548-A1 THIAZOLIDINEDIONE ENERGY RESTRICTION-MIMETIC AGENTS THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2011-04-14 — — WO claimed
US-20110086895-A1 THIAZOLIDINEDIONE ENERGY RESTRICTION-MIMETIC AGENTS THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2011-04-14 — — US claimed
US-8383656-B2 Thiazolidinedione energy restriction-mimetic agents THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2013-02-26 — — US disclosed
US-8383656-B2 Thiazolidinedione energy restriction-mimetic agents THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2013-02-26 — — US disclosed
EP-2488027-A1 THIAZOLIDINEDIONE ENERGY RESTRICTION-MIMETIC AGENTS The Ohio State University Research Foundation (US) 2012-08-22 — — EP disclosed
WO-2011044548-A1 THIAZOLIDINEDIONE ENERGY RESTRICTION-MIMETIC AGENTS THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2011-04-14 — — WO disclosed
WO-2011044548-A1 THIAZOLIDINEDIONE ENERGY RESTRICTION-MIMETIC AGENTS THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2011-04-14 — — WO disclosed
US-20110086895-A1 THIAZOLIDINEDIONE ENERGY RESTRICTION-MIMETIC AGENTS THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2011-04-14 — — US disclosed
US-20110086895-A1 THIAZOLIDINEDIONE ENERGY RESTRICTION-MIMETIC AGENTS THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2011-04-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110086895-A1 THIAZOLIDINEDIONE ENERGY RESTRICTION-MIMETIC AGENTS PCK2, AK2, SIRT6 SLC2A1 76/4885MEN1 4141/4885KMT2A 1663/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback